Abpro Holdings, Inc. Issues Notice of Delisting from Nasdaq and Transfer to OTC Pink Market

Key Points:

• Abpro Holdings, Inc. (“the Company”) has received an official notice from the Nasdaq Listing and Hearing Review Council affirming its delisting from the Nasdaq Stock Market.
• The delisting decision stems from the Company’s failure to comply with the minimum equity requirements set by Nasdaq, following a previous Panel decision on November 10, 2025.
• Effective February 23, 2026, Abpro’s securities—including both common stock and public warrants—have been removed from Nasdaq and are now trading on the OTC Pink Ltd. tier.
• The Company’s trading symbols are ABP for its common stock and ABPWW for its warrants, both of which are now listed on OTC Pink.
• This Form 8-K filing is not an amendment, nor does it involve written communications under Rule 425, soliciting material under Rule 14a-12, or pre-commencement tender offers under Rules 14d-2(b) or 13e-4(c).
• Abpro Holdings, Inc. is classified as an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.

Details for Investors and Shareholders

Delisting Details:
On May 28, 2026, Abpro Holdings, Inc. received a written notification from the Nasdaq Listing and Hearing Review Council. The Council reaffirmed the earlier decision by the Nasdaq Hearings Panel to delist the Company due to its inability to meet the minimum equity requirements as stipulated in the Panel’s decision from November 10, 2025.
Impact on Trading and Shareholder Value:
As a result of the delisting, Abpro’s securities have been transferred from Nasdaq to the OTC Pink Ltd. tier. This transition occurred as of February 23, 2026. The Company’s common stock (trading symbol: ABP) and public warrants (trading symbol: ABPWW, exercisable for one share of Common Stock at an exercise price of \$114.90) are now quoted on OTC Pink.
Potential Price Sensitivity:
The move from Nasdaq to OTC Pink may significantly impact the liquidity and perceived value of Abpro’s shares and warrants. OTC Pink is a less regulated and less liquid marketplace compared to Nasdaq, which often leads to reduced trading volumes and higher volatility. Investors should be aware that this change could affect the ability to buy or sell shares at desired prices and may increase risks associated with holding Abpro securities.
Forward-Looking Statements:
The Company has indicated that Nasdaq is expected to file a Form 25 with the SEC, which will complete the delisting process. Abpro is also monitoring the eligibility of its common stock and public warrants for continued quotation on the OTC Pink Market. The Company cautions that forward-looking statements regarding the potential for regaining compliance with Nasdaq listing rules or future trading on OTC markets are subject to risks and uncertainties, as detailed in its Annual Report on Form 10-K and other SEC filings.
Emerging Growth Company Status:
Abpro Holdings, Inc. is an emerging growth company under Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Securities Exchange Act of 1934. Notably, the Company has not opted for the extended transition period for new accounting standards, which could affect its financial reporting.

Important Shareholder Considerations

• Delisting from Nasdaq is a material event likely to affect share price and liquidity.
• Trading on OTC Pink may expose shareholders to higher risks and lower transparency.
• No written communications, soliciting material, or tender offer activities are associated with this filing.
• Shareholders should monitor further SEC filings and Company updates for developments regarding compliance and market eligibility.

Security Information

Cautionary Statement

This article contains forward-looking statements, including statements regarding Nasdaq’s expected filing of Form 25, eligibility for continued quotation on OTC Pink, and the Company’s compliance status. Actual results and developments may differ materially due to risks and uncertainties. Investors are strongly encouraged to review Abpro Holdings, Inc.’s SEC filings and consult financial advisors before making investment decisions.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. All information is based on the Company’s public SEC filings and may be subject to change. Investors should exercise due diligence and consult with professionals regarding the implications of the Company’s delisting and transfer to OTC Pink.

View Abpro Holdings, Inc. Historical chart here